Trial success for diabetes pill
Israel’s Oramed announced good results of its Phase 2b trials of ORMD-0801 treatment for Type 2 diabetes. Oramed will now discuss its Phase 3 plans with the US FDA.
Breakthrough designation for corneal implant
Israel’s EyeYon Medical has been awarded Breakthrough Device designation for its EndoArt polymer film implant, attached to the posterior corneal surface, to treat chronic corneal edema. EndoArt has been successful in early human clinical trials.
Only take the vitamins you need
Israeli app Nutricco monitors a person’s nutrient intake, provides dietary advice and delivers missing vitamins to your home. It is intended for those who currently waste money and risk their health by taking unnecessary supplements.
Smells to boost memory while you sleep
Scientists from Tel Aviv University and Israel’s Weizmann Institute have demonstrated that administering certain scents during sleep bolsters memory processes in the brain. The study tested memory recall after using rose scent while memorizing words and then during a short nap.
EU approval for blood pressure wristband monitor
In Sep 2019 Israel’s Biobeat received FDA approval for its medical smartwatch and patch . It has now also received CE Mark approval. The smartwatch measures blood pressure, cardiac output, stroke volume, blood oxygenation and heart rate.
A surgical sewing-machine
Israel’s Anchora Medical develops single-use suturing devices used to bring soft tissue into the desired placement during open and minimally invasive surgeries. Anchora has just raised $4.5 million in a funding round led by Japan’s Hoya Corporation.
Building an imaging system for prostate cancer
Israel’s Isotopia Molecular Imaging has entered into a development partnership with Germany’s Eckert & Ziegler for the development of its PSMA-11-Kit for prostate cancer imaging. Isotopia’s team includes some of Israel’s leading scientists.
Predicting success of cancer treatments
Israeli scientists are frequently finding new ways of personalizing cancer treatments. Some are based on genetics or proteins expressed by the body . Now Weizmann Institute researchers are devising a system to predict how patients will respond to immunotherapy.
Unlocking more medical data
Israel’s MDClone organizes patient data to help medical research in Israel and in the US. It has now expanded to Canada with The Ottawa Hospital – one of Canada’s largest hospitals. MDClone’s technology can potentially benefit thousands of Canadians.
Helping coronavirus patients breathe
Doctors at Jerusalem’s Alyn hospital developed Coughsync some 10 years ago to help relieve lung congestion in physically challenged and disabled children. Now it is being mass-produced to help clear secretions from the lungs of Chinese coronavirus patients on ventilators.